Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3766091012 | Rivastigmine 396 microgram/hour prolonged-release transdermal patch | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3766092017 | Product containing precisely rivastigmine 396 microgram/1 hour prolonged-release transdermal patch (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Rivastigmine 396 microgram/hour prolonged-release transdermal patch | Has precise active ingredient | Rivastigmine (substance) | true | Inferred relationship | Some | 1 | |
| Rivastigmine 396 microgram/hour prolonged-release transdermal patch | Has concentration strength numerator unit | microgram (qualifier value) | true | Inferred relationship | Some | 1 | |
| Rivastigmine 396 microgram/hour prolonged-release transdermal patch | Plays role | Antidementia therapeutic role (role) | true | Inferred relationship | Some | ||
| Rivastigmine 396 microgram/hour prolonged-release transdermal patch | Has concentration strength denominator unit | hour | true | Inferred relationship | Some | 1 | |
| Rivastigmine 396 microgram/hour prolonged-release transdermal patch | Has concentration strength numerator value (attribute) | 396 | false | Inferred relationship | Some | 1 | |
| Rivastigmine 396 microgram/hour prolonged-release transdermal patch | Has basis of strength substance (attribute) | Rivastigmine (substance) | true | Inferred relationship | Some | 1 | |
| Rivastigmine 396 microgram/hour prolonged-release transdermal patch | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| Rivastigmine 396 microgram/hour prolonged-release transdermal patch | est un(e) (attribut) | Product containing only rivastigmine in transdermal dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Rivastigmine 396 microgram/hour prolonged-release transdermal patch | a une forme pharmaceutique (attribut) | Prolonged-release transdermal patch (dose form) | true | Inferred relationship | Some | ||
| Rivastigmine 396 microgram/hour prolonged-release transdermal patch | Has concentration strength denominator value | un | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR